AbbVie’s Earnings Beat Wall Street’s Estimates. Investors Are Still Worried

AbbVie delivered a strong earnings beat this week, driven by its immunology portfolio. WSJ’s David Wainer explains why Wall Street is still jittery.

#wsj #thewallstreetjournal #pharma